Table 4 Adjusted Cox regression (Model 1) of the combined contributions of kynurenic acid and neopterin in stroke, mortality and the composite endpoint (stroke and death)

KA

0.78

(0.39, 1.57)

0.492

0.57

(0.33, 0.97)

0.038

0.72

(0.46, 1.10)

0.131

Neopterin

1.48

(0.83, 1.57)

0.177

1.61

(1.02, 2.54)

0.040

1.59

(1.11, 2.27)

0.011

Age

0.98

(0.51, 2.61)

0.949

1.11

(0.60, 2.06)

0.746

1.09

(0.68, 1.76)

0.720

Sex

1.39

(0.73, 2.66)

0.314

1.61

(1.00, 2.62)

0.052

1.43

(0.97, 2.10)

0.071

Prior CeVD

1.37

(0.87, 2.17)

0.175

1.56

(1.10, 2.22)

0.012

1.44

(1.08, 1.91)

0.012

mRS

0.97

(0.46, 2.05)

0.945

3.25

(1.77, 5.96)

< 0.001

2.24

(1.40, 3.57)

0.001

Creatinine

1.31

(0.20, 3.38)

0.583

2.23

(1.12, 4.42)

0.022

1.65

(0.93, 2.92)

0.085